By Michael Irving May 13, 2021 Researchers have reprogrammed immune cells that were previously hijacked by cancer to wipe out the disease sciencepics/Depositphotos One of cancer’s crafty tricks involves manipulating the host’s immune cells to protect the tumors instead of fighting them. But now, researchers at Massachusetts General Hospital (MGH) have turned the tables around...
by University College London Credit: CC0 Public Domain Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world. Each year, globally, chronic HBV causes an estimated 880,000 deaths from liver cirrhosis and hepatocellular carcinoma/liver cancer (HCC). The pioneering study used immune cells isolated...
